Sodium Bicarbonate Supplementation in Combat Sports Athletes

January 14, 2018 updated by: Poznan University of Life Sciences

The Effect of Sodium Bicarbonate Supplementation on Physical and Specific Performance Capacity in Combat Sports Athletes

The purpose of this study was to verify the effect of 10-day sodium bicarbonate (NaHCO3) and placebo (PLA) supplementation on physical and specific performance capacity, as well as concentrations of the selected biochemical blood markers in trained combat sports athletes, in a randomised, double-blind, placebo-controlled trial.

Study Overview

Detailed Description

Sodium bicarbonate (NaHCO3) was proposed as an ergogenic agent, because it improves high-intensity and resistance exercise performance. Until now the major limitation to NaHCO3 supplementation has been the gastrointestinal (GI) side effects. Therefore, this study aims to examine the effect of chronic, progressive-dose NaHCO3 ingestion on physical capacity and specific performance capacity, and concentrations of the selected biochemical blood markers in trained combat sports athletes, in a randomised, double-blind, placebo-controlled trial.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wielkopolska
      • Poznań, Wielkopolska, Poland, 60-624
        • Poznan University of Life Sciences, ul.Wojska Polskiego 31

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • written informed consent from all participants before the study (included aslo informed consents to the participation in the study of athletes under the age of 18 obtained from their parents)
  • a current medical clearance to practice sports,
  • training experience: at least 4 years (of combat sport training),
  • minimum of 4 workout sessions (combat sport) a week,

Exclusion Criteria:

  • current injury,
  • any health-related contraindication,
  • declared general feeling of being unwell,
  • unwilling to follow the study protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sodium bicarbonate supplementation
Group taking oral NaHCO3 supplementation in a progressive-dose regimen.
The experimental procedure for each athlete included a 10-day NaHCO3 supplementation in a progressive-dose regimen in order to reduce the likelihood of gastrointestinal side effects (from 25 to 100 mg ∙ kg-1). NaHCO3 was administered in the form of unmarked disk-shaped tablets (Alkala T, SANUM, Poland). The tablets were ingested with at least 250 mL of water and could be either swallowed or dissolved in the mouth. On training days the supplements were taken in the morning, in the evening and 1.5 hours before training session. On rest days the supplements were taken in the morning, in the afternoon and in the evening.
Placebo Comparator: Placebo treatment
Group taking oral supplementation with placebo (maltodextrin with NaCl) in a similar tablet form prepared by the same producer as NaHCO3 tablets.
The experimental procedure for each athlete included a 10-day placebo administration. Placebo was ingested with at least 250 mL of water. On training days the supplements were taken in the morning, in the evening and 1.5 hours before training session. On rest days the supplements were taken in the morning, in the afternoon and in the evening.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in anaerobic capacity after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
The Wingate Anaerobic Test (WAnT)
Baseline and after 10 days
Changes in specific performance capacity after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
The wrestler's special endurance test - projective test with dummy (DT)
Baseline and after 10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of red and white blood cell concentration in blood after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
Red blood cells (RBC) [mln/mm³] and white blood cells (WBC) [mln/mm³] concentration analysis
Baseline and after 10 days
Changes in blood glucose and hemoglobin concentration after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
Hemoglobin (Hb) [g/dl] and glucose [g/dl] concentration analysis
Baseline and after 10 days
Changes in blood hematocrit levels after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
Hematocrit (HCT) [%] level analysis
Baseline and after 10 days
Changes of lactate and pyruvate concentration in blood after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
Lactate [mmol/L] and pyruvate [mmol/L] concentration analysis
Baseline and after 10 days
Changes of creatine kinase and lactate dehydrogenase activity in blood after sodium bicarbonate supplementation
Time Frame: Baseline and after 10 days
Creatine kinase [U/L] and lactate dehydrogenase [U/L] activity analysis
Baseline and after 10 days
Changes in polyphenols and albumin concentration
Time Frame: Baseline and after 10 days
Polyphenols [g/L] and and albumin [g/L] concentration analysis
Baseline and after 10 days
Changes in FRAP concentration
Time Frame: Baseline and after 10 days
FRAP [µmol/L] concentration analysis
Baseline and after 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jan Jeszka, Professor, Poznan University of Life Sciences, ul. Wojska Polskiego 31, Poznań, Wielkopolska, Poland, 60-624

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2014

Primary Completion (Actual)

January 20, 2015

Study Completion (Actual)

April 5, 2015

Study Registration Dates

First Submitted

January 14, 2018

First Submitted That Met QC Criteria

January 14, 2018

First Posted (Actual)

January 23, 2018

Study Record Updates

Last Update Posted (Actual)

January 23, 2018

Last Update Submitted That Met QC Criteria

January 14, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • ULS00003

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Shared data will be exclusively related to the level recorded indicators (anaerobic capacity and specific performance capacity indicators, levels of biochemical markers, body composition), without personal data. The data obtained will be attached to scientific publications, depending on the requirements of the journal.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supplementation

Clinical Trials on Sodium bicarbonate supplementation

3
Subscribe